NO164472C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte 2-(monokondenserte (3,4- og 5,6)-pyridylalkylensulfinyl)-benzimidazoler. - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte 2-(monokondenserte (3,4- og 5,6)-pyridylalkylensulfinyl)-benzimidazoler.Info
- Publication number
- NO164472C NO164472C NO842645A NO842645A NO164472C NO 164472 C NO164472 C NO 164472C NO 842645 A NO842645 A NO 842645A NO 842645 A NO842645 A NO 842645A NO 164472 C NO164472 C NO 164472C
- Authority
- NO
- Norway
- Prior art keywords
- pyridylalkylensulphinyl
- monocondensed
- benzimidazoles
- preparation
- therapeutically active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US51046883A | 1983-07-01 | 1983-07-01 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO842645L NO842645L (no) | 1985-01-02 |
| NO164472B NO164472B (no) | 1990-07-02 |
| NO164472C true NO164472C (no) | 1990-10-10 |
Family
ID=24030850
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO842645A NO164472C (no) | 1983-07-01 | 1984-06-29 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte 2-(monokondenserte (3,4- og 5,6)-pyridylalkylensulfinyl)-benzimidazoler. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0130729A3 (no) |
| JP (1) | JPS6036483A (no) |
| KR (1) | KR890000881B1 (no) |
| AU (1) | AU573744B2 (no) |
| CA (1) | CA1259070A (no) |
| DK (1) | DK321884A (no) |
| ES (1) | ES533853A0 (no) |
| FI (1) | FI83514C (no) |
| GR (1) | GR81445B (no) |
| IL (1) | IL72159A (no) |
| MX (1) | MX161283A (no) |
| NO (1) | NO164472C (no) |
| NZ (1) | NZ208553A (no) |
| PH (1) | PH20625A (no) |
| ZA (1) | ZA844953B (no) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0174717B1 (en) | 1984-07-06 | 1992-01-22 | FISONS plc | Benzimidazoles, and their production formulation and use as gastric acid secretion inhibitors |
| AU568441B2 (en) * | 1984-09-24 | 1987-12-24 | Upjohn Company, The | 2-(pyridylalkenesulfinyl) benzimidazole derivatives |
| DK585485A (da) * | 1984-12-18 | 1986-08-08 | Utsuka Pharm Co Ltd | Tetrahydroquinolinderivat, imidazopyridinderivat, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat med mindst en saadan forbindelse |
| EP0204215B1 (en) | 1985-05-24 | 1993-08-11 | G.D. Searle & Co. | 2-[(1H-benzimidazol-2-ylsulfinyl)methyl]-benzenamines |
| US5869513A (en) * | 1985-05-24 | 1999-02-09 | G. D. Searle & Co. | 2- (1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines |
| FI864138A (fi) * | 1985-10-16 | 1987-04-17 | Fisons Plc | Heterocykliska blandningar. |
| DE3773240D1 (de) * | 1986-03-28 | 1991-10-31 | Otsuka Pharma Co Ltd | Hydrochinolinverbindungen, diese enthaltende zusammensetzungen und verfahren zu ihrer herstellung. |
| ATE56717T1 (de) * | 1986-07-01 | 1990-10-15 | Shionogi & Co | Substituierte isoquinolinderivate und antiulcusmittel. |
| US4687775A (en) * | 1986-07-17 | 1987-08-18 | G. D. Searle & Co. | 2-[(Imidazo[1,2-a]pyridinylmethyl)sulfinyl]-1H-benzimidazoles |
| US4772619A (en) * | 1986-07-17 | 1988-09-20 | G. D. Searle & Co. | [(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines |
| US4721718A (en) * | 1986-08-18 | 1988-01-26 | G. D. Searle & Co. | 2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles useful in the treatment and prevention of ulcers |
| JPS6452782A (en) * | 1987-05-19 | 1989-02-28 | Shionogi & Co | Thienopyridine derivative and antiulcer agent |
| US4839365A (en) * | 1987-05-19 | 1989-06-13 | Shinogi & Co., Ltd. | Thienopyridine derivatives useful in treating gastric ulcers |
| AU2395095A (en) | 1994-04-29 | 1995-11-29 | G.D. Searle & Co. | Method of using (h+/k+) atpase inhibitors as antiviral agents |
| WO1997000875A1 (en) * | 1995-06-21 | 1997-01-09 | Korea Research Institute Of Chemical Technology | Benzimidazole derivatives containing fused pyridine |
| PL186605B1 (pl) * | 1995-09-21 | 2004-01-30 | Pharma Pass Llc | Tabletka lub mikrotabletka zawierająca rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol oraz sposób wytwarzania tabletek lub mikrotabletek zawierających rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol |
| US20060024362A1 (en) | 2004-07-29 | 2006-02-02 | Pawan Seth | Composition comprising a benzimidazole and process for its manufacture |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE416649B (sv) * | 1974-05-16 | 1981-01-26 | Haessle Ab | Forfarande for framstellning av foreningar som paverkar magsyrasekretionen |
| SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
| US4359465A (en) * | 1980-07-28 | 1982-11-16 | The Upjohn Company | Methods for treating gastrointestinal inflammation |
| IL66340A (en) * | 1981-08-13 | 1986-08-31 | Haessle Ab | Pharmaceutical compositions comprising pyridylmethyl-thiobenzimidazole derivatives,certain such novel derivatives and their preparation |
| US4472409A (en) * | 1981-11-05 | 1984-09-18 | Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung | 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects |
| SE8300736D0 (sv) * | 1983-02-11 | 1983-02-11 | Haessle Ab | Novel pharmacologically active compounds |
-
1984
- 1984-06-14 CA CA000456621A patent/CA1259070A/en not_active Expired
- 1984-06-18 NZ NZ208553A patent/NZ208553A/en unknown
- 1984-06-18 EP EP84304112A patent/EP0130729A3/en not_active Withdrawn
- 1984-06-19 IL IL72159A patent/IL72159A/xx unknown
- 1984-06-25 MX MX201779A patent/MX161283A/es unknown
- 1984-06-27 GR GR75136A patent/GR81445B/el unknown
- 1984-06-28 AU AU29996/84A patent/AU573744B2/en not_active Ceased
- 1984-06-28 ZA ZA844953A patent/ZA844953B/xx unknown
- 1984-06-29 ES ES533853A patent/ES533853A0/es active Granted
- 1984-06-29 FI FI842631A patent/FI83514C/fi not_active IP Right Cessation
- 1984-06-29 DK DK321884A patent/DK321884A/da not_active Application Discontinuation
- 1984-06-29 NO NO842645A patent/NO164472C/no unknown
- 1984-06-29 PH PH30907A patent/PH20625A/en unknown
- 1984-06-30 JP JP59136436A patent/JPS6036483A/ja active Pending
- 1984-06-30 KR KR1019840003792A patent/KR890000881B1/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ208553A (en) | 1987-07-31 |
| KR890000881B1 (ko) | 1989-04-12 |
| DK321884A (da) | 1985-01-02 |
| FI842631A (fi) | 1985-01-02 |
| FI83514B (fi) | 1991-04-15 |
| ZA844953B (en) | 1985-02-27 |
| FI842631A0 (fi) | 1984-06-29 |
| NO164472B (no) | 1990-07-02 |
| ES8601914A1 (es) | 1985-12-01 |
| NO842645L (no) | 1985-01-02 |
| KR850001201A (ko) | 1985-03-16 |
| EP0130729A2 (en) | 1985-01-09 |
| IL72159A0 (en) | 1984-10-31 |
| JPS6036483A (ja) | 1985-02-25 |
| AU573744B2 (en) | 1988-06-23 |
| MX161283A (es) | 1990-08-28 |
| ES533853A0 (es) | 1985-12-01 |
| EP0130729A3 (en) | 1986-08-06 |
| GR81445B (no) | 1984-12-11 |
| IL72159A (en) | 1987-12-31 |
| FI83514C (fi) | 1991-07-25 |
| PH20625A (en) | 1987-03-06 |
| AU2999684A (en) | 1985-01-03 |
| CA1259070A (en) | 1989-09-05 |
| DK321884D0 (da) | 1984-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO163691C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-acryl-piperazinalkanamider. | |
| NO160521C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 13alfa- alkylgonaner. | |
| NO158021C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktivt d-fenylalanyl-l-prolyl-l-argininaldehydsulfat. | |
| NO158740C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-substituerte 2-azetidinonforbindelser. | |
| NO158540C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-penem-forbindelser. | |
| NO159089C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater. | |
| NO162238C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydro-4-oksonaftyridinderivater. | |
| NO162858C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive thiazolidinderivater. | |
| NO164097C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-(n-substituert-guanidino)-4-hetero-aryl-tiazol-derivater. | |
| NO152091C (no) | Analogifremgangsmaate ved fremstilling av antiinflammatorisk virksomme 5-substituerte 2,3-difenylthiofener | |
| NO164472C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte 2-(monokondenserte (3,4- og 5,6)-pyridylalkylensulfinyl)-benzimidazoler. | |
| NO166083C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridazodiazepinderivater. | |
| NO165841C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater. | |
| NO164168C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,7,4-triazolforbindelser. | |
| NO153370C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive, stabile s-adenosylmethionisalter. | |
| NO823520L (no) | Fremgangsmaate ved fremstilling av nye, terapeutisk aktive carbohydrater. | |
| NO165400C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive cefemforbindelser. | |
| NO165842C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-forbindelser. | |
| NO157538C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzothiazolsufonamidderivater. | |
| NO161313C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater. | |
| NO158673C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive azurenderivater. | |
| NO164416C (no) | Analogiremgangsmaate ved fremstilling av terapeutisk aktive 5-acyl-2-(1h)-pyridinoner. | |
| NO163330C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive isokinolinderivater. | |
| NO158376C (no) | Analogifremgangsmaate for fremstilling av terapeutisk virksomme rooperolforbindelser. | |
| NO163896C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive spiro-(1,8)-nafthyridin-dioner. |